Build Your Comparison

Side-by-side financial analysis
CYN logo
CYN
LIDR logo
LIDR
RBOT logo
RBOT
LAZR logo
LAZR
INVZ logo
INVZ
JPM logo
JPM
Try popular comparisons:

Stock Comparison

CYN vs LIDR vs RBOT vs LAZR vs INVZ vs JPM

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CYN
Cyngn Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$14M
5Y Perf.-100.0%
LIDR
AEye, Inc.

Auto - Parts

Consumer CyclicalNASDAQ • US
Market Cap$74M
5Y Perf.-99.0%
RBOT
Vicarious Surgical Inc.

Medical - Devices

HealthcareNYSE • US
Market Cap$3M
5Y Perf.-99.9%
LAZR
Luminar Technologies, Inc.

Auto - Parts

Consumer CyclicalNASDAQ • US
Market Cap$2M
5Y Perf.-100.0%
INVZ
Innoviz Technologies Ltd.

Auto - Parts

Consumer CyclicalNASDAQ • IL
Market Cap$137M
5Y Perf.-88.2%
JPM
JPMorgan Chase & Co.

Banks - Diversified

Financial ServicesNYSE • US
Market Cap$896.00B
5Y Perf.+88.8%

CYN vs LIDR vs RBOT vs LAZR vs INVZ vs JPM — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CYN logoCYN
LIDR logoLIDR
RBOT logoRBOT
LAZR logoLAZR
INVZ logoINVZ
JPM logoJPM
IndustrySoftware - ApplicationAuto - PartsMedical - DevicesAuto - PartsAuto - PartsBanks - Diversified
Market Cap$14M$74M$3M$2M$137M$896.00B
Revenue (TTM)$276K$270K$0.00$66M$45M$280.33B
Net Income (TTM)$-26M$-34M$-42M$-378M$-81M$57.05B
Gross Margin34.4%-144.1%9.7%60.0%
Operating Margin-99.2%-125.8%-449.6%-178.8%25.9%
Forward P/E14.4x
Total Debt$7M$235K$8M$117M$65M$942.38B
Cash & Equiv.$990K$43M$3M$20M$9M$343.34B

CYN vs LIDR vs RBOT vs LAZR vs INVZ vs JPMLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CYN
LIDR
RBOT
LAZR
INVZ
JPM
StockOct 21Jun 26Return
Cyngn Inc. (CYN)1000.0-100.0%
AEye, Inc. (LIDR)1001.0-99.0%
Vicarious Surgical … (RBOT)1000.1-99.9%
Luminar Technologie… (LAZR)1000.0-100.0%
Innoviz Technologie… (INVZ)10011.8-88.2%
JPMorgan Chase & Co. (JPM)100188.8+88.8%

Price return only. Dividends and distributions are not included.

Quick Verdict: CYN vs LIDR vs RBOT vs LAZR vs INVZ vs JPM

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: JPM leads in 4 of 6 categories (6-stock set), making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. AEye, Inc. is the stronger pick specifically for recent price momentum and sentiment. INVZ also leads in specific categories worth noting. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
🥇JPM emerged as the overall leader. Track its performance:
CYN
Cyngn Inc.
The Defensive Pick

CYN is the clearest fit if your priority is sleep-well-at-night and defensive.

  • Lower volatility, beta 2.18, Low D/E 17.6%, current ratio 8.29x
  • Beta 2.18, current ratio 8.29x
Best for: sleep-well-at-night and defensive
LIDR
AEye, Inc.
The Momentum Pick

LIDR is the #2 pick in this set and the best alternative if momentum is your priority.

  • +86.2% vs LAZR's -98.0%
Best for: momentum
RBOT
Vicarious Surgical Inc.
The Healthcare Pick

Among these 6 stocks, RBOT doesn't own a clear edge in any measured category.

Best for: healthcare exposure
LAZR
Luminar Technologies, Inc.
The Consumer Cyclical Pick

LAZR doesn't hold a clear category lead here; it's more of a secondary option in this specific comparison.

Best for: consumer cyclical exposure
INVZ
Innoviz Technologies Ltd.
The Growth Play

INVZ ranks third and is worth considering specifically for growth exposure.

  • Rev growth 127.0%, EPS growth 40.4%, 3Y rev CAGR 109.1%
  • 127.0% revenue growth vs CYN's -40.5%
Best for: growth exposure
JPM
JPMorgan Chase & Co.
The Banking Pick

JPM carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 15 yrs, beta 0.94, yield 1.9%
  • 465.8% 10Y total return vs INVZ's -93.7%
  • 20.4% margin vs LIDR's -127.0%
  • Beta 0.94 vs LIDR's 2.51
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthINVZ logoINVZ127.0% revenue growth vs CYN's -40.5%
Quality / MarginsJPM logoJPM20.4% margin vs LIDR's -127.0%
Stability / SafetyJPM logoJPMBeta 0.94 vs LIDR's 2.51
DividendsJPM logoJPM1.9% yield; 15-year raise streak; the other 5 pay no meaningful dividend
Momentum (1Y)LIDR logoLIDR+86.2% vs LAZR's -98.0%
Efficiency (ROA)JPM logoJPM1.3% ROA vs RBOT's -164.5%, ROIC 4.5% vs -116.2%

CYN vs LIDR vs RBOT vs LAZR vs INVZ vs JPM — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

Discover the Autonomous Vehicle Stocks Theme

These companies are key players in the Autonomous Vehicle Stocks ecosystem. See how they stack up against the rest of the sector.

Explore Theme
CYNCyngn Inc.

Segment breakdown not available.

LIDRAEye, Inc.
FY 2025
Product
67.4%$157,000
Technology Service
32.6%$76,000
RBOTVicarious Surgical Inc.

Segment breakdown not available.

LAZRLuminar Technologies, Inc.
FY 2025
Product
86.5%$128M
Service
13.5%$20M
INVZInnoviz Technologies Ltd.

Segment breakdown not available.

JPMJPMorgan Chase & Co.
FY 2025
Commercial And Investment Bank
43.0%$78.5B
Consumer & Community Banking
41.7%$76.0B
Asset and Wealth Management Segment
13.2%$24.1B
Segment Reporting, Reconciling Item, Corporate Nonsegment
3.9%$7.0B
Segment Reconciling Items
-1.7%$-3,134,000,000

CYN vs LIDR vs RBOT vs LAZR vs INVZ vs JPM — Financial Metrics

Side-by-side numbers across 6 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLJPMLAGGINGINVZ

Income & Cash Flow (Last 12 Months)

JPM leads this category, winning 4 of 6 comparable metrics.

JPM and RBOT operate at a comparable scale, with $280.3B and $0 in trailing revenue. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to LIDR's -127.0%. On growth, CYN holds the edge at +121.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…LAZR logoLAZRLuminar Technolog…INVZ logoINVZInnoviz Technolog…JPM logoJPMJPMorgan Chase & …
RevenueTrailing 12 months$276,397$270,000$0$66M$45M$280.3B
EBITDAEarnings before interest/tax-$26M-$34M-$41M-$297M-$74M$81.4B
Net IncomeAfter-tax profit-$26M-$34M-$42M-$378M-$81M$57.0B
Free Cash FlowCash after capex-$27M-$29M-$40M-$200M-$47M$100.9B
Gross MarginGross profit ÷ Revenue+34.4%-144.1%+9.7%+60.0%
Operating MarginEBIT ÷ Revenue-99.2%-125.8%-4.5%-178.8%+25.9%
Net MarginNet income ÷ Revenue-94.2%-127.0%-5.7%-181.5%+20.4%
FCF MarginFCF ÷ Revenue-97.1%-106.7%-3.0%-105.2%+36.0%
Rev. Growth (YoY)Latest quarter vs prior year+121.8%+57.8%-43.3%-59.0%
EPS Growth (YoY)Latest quarter vs prior year+91.1%-63.6%+58.1%-98.4%-76.2%+16.0%
JPM leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — CYN and LAZR and INVZ each lead in 1 of 3 comparable metrics.
MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…LAZR logoLAZRLuminar Technolog…INVZ logoINVZInnoviz Technolog…JPM logoJPMJPMorgan Chase & …
Market CapShares × price$14M$74M$3M$2M$137M$896.0B
Enterprise ValueMkt cap + debt − cash$19M$31M$9M$454M$193M$1.50T
Trailing P/EPrice ÷ TTM EPS-0.24x-1.78x-0.06x-0.01x-1.82x16.00x
Forward P/EPrice ÷ next-FY EPS est.14.40x
PEG RatioP/E ÷ EPS growth rate0.90x
EV / EBITDAEnterprise value multiple18.36x
Price / SalesMarket cap ÷ Revenue62.34x318.04x0.03x2.48x3.20x
Price / BookPrice ÷ Book value/share0.15x0.74x0.31x1.59x2.47x
Price / FCFMarket cap ÷ FCF8.88x
Evenly matched — CYN and LAZR and INVZ each lead in 1 of 3 comparable metrics.

Profitability & Efficiency

JPM leads this category, winning 6 of 9 comparable metrics.

JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-3 for RBOT. LIDR carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), LIDR scores 5/9 vs RBOT's 1/9, reflecting solid financial health.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…LAZR logoLAZRLuminar Technolog…INVZ logoINVZInnoviz Technolog…JPM logoJPMJPMorgan Chase & …
ROE (TTM)Return on equity-59.6%-56.2%-3.3%-101.6%+15.9%
ROA (TTM)Return on assets-48.1%-48.5%-164.5%-164.4%-57.8%+1.3%
ROICReturn on invested capital-117.2%-100.7%-116.2%-140.1%-46.9%+4.5%
ROCEReturn on capital employed-71.5%-64.7%-134.6%-198.6%-64.1%+8.9%
Piotroski ScoreFundamental quality 0–9351355
Debt / EquityFinancial leverage0.18x0.00x0.79x0.83x2.60x
Net DebtTotal debt minus cash$6M-$43M$5M$96M$56M$599.0B
Cash & Equiv.Liquid assets$990,023$43M$3M$20M$9M$343.3B
Total DebtShort + long-term debt$7M$235,000$8M$117M$65M$942.4B
Interest CoverageEBIT ÷ Interest expense-59.79x-80.57x-6.16x-46.35x0.74x
JPM leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

JPM leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $0 for CYN. Over the past 12 months, LIDR leads with a +86.2% total return vs LAZR's -98.0%. The 3-year compound annual growth rate (CAGR) favors JPM at 33.6% vs CYN's -95.5% — a key indicator of consistent wealth creation.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…LAZR logoLAZRLuminar Technolog…INVZ logoINVZInnoviz Technolog…JPM logoJPMJPMorgan Chase & …
YTD ReturnYear-to-date-54.9%-24.2%-79.8%-24.1%-35.9%-0.5%
1-Year ReturnPast 12 months-72.6%+86.2%-94.1%-98.0%-35.7%+21.8%
3-Year ReturnCumulative with dividends-100.0%-70.4%-99.2%-99.9%-78.3%+138.2%
5-Year ReturnCumulative with dividends-100.0%-99.5%-99.8%-100.0%-93.8%+118.2%
10-Year ReturnCumulative with dividends-100.0%-99.5%-99.8%-100.0%-93.7%+465.8%
CAGR (3Y)Annualised 3-year return-95.5%-33.4%-80.0%-91.5%-39.9%+33.6%
JPM leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

JPM leads this category, winning 2 of 2 comparable metrics.

JPM is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than LIDR's 2.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JPM currently trades 95.1% from its 52-week high vs LAZR's 1.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…LAZR logoLAZRLuminar Technolog…INVZ logoINVZInnoviz Technolog…JPM logoJPMJPMorgan Chase & …
Beta (5Y)Sensitivity to S&P 5002.18x2.51x2.42x2.19x2.47x0.94x
52-Week HighHighest price in past year$41.54$6.44$13.75$3.86$2.54$337.25
52-Week LowLowest price in past year$1.22$0.71$0.35$0.05$0.58$262.71
% of 52W HighCurrent price vs 52-week peak+3.0%+24.8%+3.7%+1.6%+24.3%+95.1%
RSI (14)Momentum oscillator 0–10036.036.736.536.241.059.1
Avg Volume (50D)Average daily shares traded277K3.4M14K418K2.7M7.0M
JPM leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

JPM leads this category, winning 1 of 1 comparable metric.

Analyst consensus: LIDR as "Hold", INVZ as "Buy", JPM as "Buy". Consensus price targets imply 871.7% upside for INVZ (target: $6) vs 5.9% for JPM (target: $340). JPM is the only dividend payer here at 1.86% yield — a key consideration for income-focused portfolios.

MetricCYN logoCYNCyngn Inc.LIDR logoLIDRAEye, Inc.RBOT logoRBOTVicarious Surgica…LAZR logoLAZRLuminar Technolog…INVZ logoINVZInnoviz Technolog…JPM logoJPMJPMorgan Chase & …
Analyst RatingConsensus buy/hold/sellHoldBuyBuy
Price TargetConsensus 12-month target$12.00$6.00$339.75
# AnalystsCovering analysts4561
Dividend YieldAnnual dividend ÷ price+1.9%
Dividend StreakConsecutive years of raises215
Dividend / ShareAnnual DPS$5.95
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%0.0%0.0%+3.9%
JPM leads this category, winning 1 of 1 comparable metric.
Key Takeaway

JPM leads in 5 of 6 categories — strongest in Income & Cash Flow and Profitability & Efficiency. 1 category is tied.

Best OverallJPMorgan Chase & Co. (JPM)Leads 5 of 6 categories
Loading custom metrics...

CYN vs LIDR vs RBOT vs LAZR vs INVZ vs JPM: Key Questions Answered

9 questions · data-driven answers · updated daily

01

Is CYN or LIDR or RBOT or LAZR or INVZ or JPM a better buy right now?

For growth investors, Innoviz Technologies Ltd.

(INVZ) is the stronger pick with 127. 0% revenue growth year-over-year, versus -40. 5% for Cyngn Inc. (CYN). JPMorgan Chase & Co. (JPM) offers the better valuation at 16. 0x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate Innoviz Technologies Ltd. (INVZ) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — CYN or LIDR or RBOT or LAZR or INVZ or JPM?

Over the past 5 years, JPMorgan Chase & Co.

(JPM) delivered a total return of +118. 2%, compared to -100. 0% for Cyngn Inc. (CYN). Over 10 years, the gap is even starker: JPM returned +465. 8% versus CYN's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — CYN or LIDR or RBOT or LAZR or INVZ or JPM?

By beta (market sensitivity over 5 years), JPMorgan Chase & Co.

(JPM) is the lower-risk stock at 0. 94β versus AEye, Inc. 's 2. 51β — meaning LIDR is approximately 166% more volatile than JPM relative to the S&P 500. On balance sheet safety, AEye, Inc. (LIDR) carries a lower debt/equity ratio of 0% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.

04

Which is growing faster — CYN or LIDR or RBOT or LAZR or INVZ or JPM?

By revenue growth (latest reported year), Innoviz Technologies Ltd.

(INVZ) is pulling ahead at 127. 0% versus -40. 5% for Cyngn Inc. (CYN). On earnings-per-share growth, the picture is similar: AEye, Inc. grew EPS 79. 9% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Over a 3-year CAGR, INVZ leads at 109. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — CYN or LIDR or RBOT or LAZR or INVZ or JPM?

JPMorgan Chase & Co.

(JPM) is the more profitable company, earning 20. 4% net margin versus -145. 7% for AEye, Inc. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -136. 2% for LIDR. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is CYN or LIDR or RBOT or LAZR or INVZ or JPM more undervalued right now?

Analyst consensus price targets imply the most upside for INVZ: 871.

7% to $6. 00.

07

Which pays a better dividend — CYN or LIDR or RBOT or LAZR or INVZ or JPM?

In this comparison, JPM (1.

9% yield) pays a dividend. CYN, LIDR, RBOT, LAZR, INVZ do not pay a meaningful dividend and should not be held primarily for income.

08

Is CYN or LIDR or RBOT or LAZR or INVZ or JPM better for a retirement portfolio?

For long-horizon retirement investors, JPMorgan Chase & Co.

(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 94), 1. 9% yield, +465. 8% 10Y return). Cyngn Inc. (CYN) carries a higher beta of 2. 18 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JPM: +465. 8%, CYN: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between CYN and LIDR and RBOT and LAZR and INVZ and JPM?

These companies operate in different sectors (CYN (Technology) and LIDR (Consumer Cyclical) and RBOT (Healthcare) and LAZR (Consumer Cyclical) and INVZ (Consumer Cyclical) and JPM (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CYN is a small-cap quality compounder stock; LIDR is a small-cap high-growth stock; RBOT is a small-cap quality compounder stock; LAZR is a small-cap quality compounder stock; INVZ is a small-cap high-growth stock; JPM is a large-cap deep-value stock. JPM pays a dividend while CYN, LIDR, RBOT, LAZR, INVZ do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.